Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Apremilast improves symptoms, QoL in patients with genital psoriasis
Treatment with apremilast results in a significant reduction in genital psoriasis (G-PsO), as well as improvements in itch, pain, discomfort, redness, and quality of life (QoL), in patients with moderate-to-severe G-PsO who are intolerant to topical therapies, a study has shown.
Apremilast improves symptoms, QoL in patients with genital psoriasis
15 Mar 2024Alogliptin ups risk of heart failure exacerbation in T2D patients
In type 2 diabetes (T2D) patients with established heart failure (HF), use of alogliptin appears to contribute to an increased risk of HF exacerbation, reveals a study.
Alogliptin ups risk of heart failure exacerbation in T2D patients
13 Mar 2024Novel investigational combo a breakthrough in HIV treatment?
Phase II data presented at CROI 2024 demonstrated the ability of an investigational, long-acting, oral once-weekly regimen comprising islatravir, a nucleoside reverse transcriptase translocation inhibitor, and lenacapavir, a first-in-class capsid inhibitor, to maintain viral suppression at week 24 in virologically suppressed people living with HIV (PWH).